Werewolf Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.36

+0.05 (+16.85%)

As of Jun 30, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +11,103.1% upside

Low Target $26.90

Average Target $40.32

High Target $53.74

Current Price $0.36

Current
$0.36

Target
$40.32

$26.90 $40.32 avg $53.74

Scenario Analysis

Bear Case

$26.90

7,374.3%

Low target

Base Case

$40.32

+11,103.1%

Avg target

Bull Case

$53.74

+14,831.9%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$2.38

-84.9% from high

52-Week Low

$0.33

+9.0% from low

Target vs 52W High

$40.32

+1,594.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%